COVID-19 Pandemic and Angina Pectoris: What If the Pain Pathway Is Pharmaceutically Modulated?

Siniorakis, Eftychios; Arvanitakis, Spyridon; Sfakianaki, Titika; Katsianis, Antonis; Konstantopoulou, Georgia; Papagiannopoulou, Veneta

Siniorakis, Eftychios; Arvanitakis, Spyridon; Sfakianaki, Titika; Katsianis, Antonis; Konstantopoulou, Georgia; Papagiannopoulou, Veneta.

Afiliação

Siniorakis E; Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.
Arvanitakis S; Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.
Sfakianaki T; Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.
Katsianis A; Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.
Konstantopoulou G; Department of Pain Medicine, Sotiria Chest Diseases Hospital, Athens, Greece.
Papagiannopoulou V; Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.

Pain Med ; 21(11): 3246-3247, 2020 11 01.

Article em En | MEDLINE | ID: mdl-32893306

Assuntos

COVID-19; Pandemias; Angina Pectoris/epidemiologia; China; Humanos; Dor; Manejo da Dor; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Pain Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google